Low-dose naltrexone as treatment for epidermolysis bullosa pruriginosa-associated refractory pruritus (Abstract)
Low-dose naltrexone as treatment for epidermolysis bullosa pruriginosa-associated refractory pruritus Case Reports; JAAD Case Rep 19 June 2023 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10339115/ A rare subtype of epidermolysis bullosa, epidermolysis bullosa pruriginosa (EBP) is characterized by severely pruritic lichenified and hypertrophic prurigo-like nodules and plaques secondary to chronic itching. No standard first-line therapy currently exists. Reported is a case of […]
Dawn Ipsen, PharmD – LDN Radio Show May 2023 (LDN; low dose naltrexone)
D Today we’re joined by pharmacist Dr Dawn Ipsen who’s the owner of two pharmacies in Washington State, Kuslers Pharmacy and Clark Pharmacy. Could you tell us what it was that inspired you to become a pharmacist? I knew early on as a high schooler that I wanted to have a doctorate degree in something […]
Ray Solano, RPh – LDN Radio Show August 2023 (LDN; low dose naltrexone)
Welcome to the LDN Radio Show brought to you by the LDN Research Trust. I’m your host Linda Elsegood. Today we’re joined by Ray Solano from PD Labs. He’s also a nutritionist. Could you tell us a bit of background about yourself? I am dedicated to getting out the word on personalized medications. We […]
Would You Combine Topical Naltrexone for Scalp PRP for Male Pattern Alopecia?
What Can Explain the Efficacy of Low Dose Naltrexone (LDN) for Hailey Hailey Disease?
Can Low Dose Naltrexone (LDN) and Pericalcitol be Combined in Transdermal Periacidol?
Is Low Dose Naltrexone (LDN) Helpful for Dermatology?
How Long Does it Take for Low Dose Naltrexone (LDN) to Help with Dermatological Issues?
Do Any of the Topical Creams Cause Photosensitivity?
Segmental Darier’s disease: A case report (Abstract)
Segmental Darier’s disease: A case report SAGE Open Med Case Rep 03 April 2023 https://pubmed.ncbi.nlm.nih.gov/37032996/ Segmental Darier’s disease is an uncommon subtype of Darier’s genodermatosis, resulting from a mutation in the ATPase type 2 during early embryogenesis. It typically presents as a persistent, pruritic papular eruption following the lines of Blaschko. Histopathology of Darier’s disease […]